Immunogen | IMGN - Loan Capital

Immunogen reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
Astellas Pharma 4503:JP JPY 148.74B 66.35B
AstraZeneca AZN:LN USD 23.69B 9M
Emergent Biosolutions EBS:US USD 448.5M 583.6M
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Heron Therapeutics HRTX:US USD 149.28M 50K
Karyopharm Therapeutics KPTI:US USD 302.82M 69K
Novartis NVS:US USD 21.78B 547M
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 21.39B 978M